Person's Publications

Steinkellner H, Kempaiah P, Beribisky A, Pferschy S, Etzler J, Huber A, Sarne V, Neuhaus W, Kuttke M, Bauer J, Arunachalam J, Christodoulou J, Dressel R, Mildner A, Prinz M, Laccone F (2022) TAT-MeCP2 protein variants rescue disease phenotypes in human and mouse models of Rett syndrome Int J Biol Macromol, 209: 972-983

Komorowski A, Weidenauer A, Murgaš M, Sauerzopf U, Wadsak W, Mitterhauser M, Bauer M, Hacker M, Praschak-Rieder N, Kasper S, Lanzenberger R, Willeit M (2020) Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain Neuroimage, 223: 117270
| Weblink |
Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer B, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte H, Lanzenberger R, Mossaheb N, Zimprich A, Rusjan P, Dorffner G, Mitterhauser M, Hacker M, Pezawas L, Kasper S, Wadsak W, Praschak-Rieder N, Willeit M (2020) On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study Transl Psychiat, 10 (2): 2
| Weblink |

Dodd S, Bauer M, Carvalho A, Eyre H, Fava M, Kasper S, Kennedy S, Khoo J, Lopez Jaramillo C, Malhi G, McIntyre R, Mitchell P, Castro A, Ratheesh A, Severus E, Suppes T, Trivedi M, Thase M, Yatham L, Young A, Berk M (2020) A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough? World J Biol Psychiatry, 22 (7): 483-494
| Weblink |

Hienert M, Ritter P, Bauer M, Lanzenberger R, Kasper S (2019) Die klinische Anwendung von Milnacipran in Österreich und Deutschland Nervenheilkunde, 38 (04): 178-183
| Weblink |

Benedetti F, Avery D, Bauer M, Bunney W, Çaliyurt O, Camardese G, Colombo C, Dallaspezia S, Henriksen T, Kasper S, Kuriyama K, Lam R, Martiny K, Meesters Y, Mishima K, Schulte R, Suzuki M, Święcicki �, Uchiyama M, Veale D, Winkler D, Wu J, Kupeli N, Yoshiike T, Yu X (2018) Evidence for the Efficacy of Bright Light Therapy for Bipolar Depression Am J Psychiatry, 175 (9): 905-906
| Weblink |

Weidenauer A, Sauerzopf U, Bartova L, Bauer M, Praschak-Rieder N, Kasper S, Willeit M (2018) Sensibilisierung auf Amphetamine: Bedeutung für die Schizophrenie- und Suchtforschung Journal für Neurologie, Neurochirurgie und Psychiatrie, 19 (2): 66-der 71
| Weblink |

Litvan Z, Bauer M, Kasper S, Frey R (2017) Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia Int Psychogeriatr, 29 (07): 1223-1225
| Weblink |

Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Praschak-Rieder N, Sitte H, Kasper S, Willeit M (2017) Making Sense of: Sensitization in Schizophrenia Int J Neuropsychopharmacol, 20 (1): 1-10
| Weblink |

Bauer M, Karch R, Zeitlinger M, Liu J, Koepp M, Asselin M, Sisodiya S, Hainfellner J, Wadsak W, Mitterhauser M, Muller M, Pataraia E, Langer O (2014) In vivo P-glycoprotein function before and after epilepsy surgery Neurology,